Atea Pharmaceuticals shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $117k | 39k | 3.05 |
| 2023-09-30 | $121k | 40k | 3.00 |
| 2023-06-30 | $140k | 37k | 3.74 |
| 2023-03-31 | $192k | 57k | 3.35 |
| 2022-12-31 | $151k | 32k | 4.81 |
| 2022-09-30 | $176k | 31k | 5.68 |
| 2022-06-30 | $1.9M | 267k | 7.10 |
| 2022-03-31 | $1.8M | 247k | 7.23 |
| 2021-12-31 | $654k | 73k | 8.94 |
| 2021-09-30 | $3.3M | 94k | 35.05 |
| 2021-06-30 | $843k | 39k | 21.74 |
| 2021-03-31 | $610k | 9.7k | 62.80 |
| 2020-12-31 | $454k | 11k | 42.86 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft